Mereo BioPharma (MREO) Assets Average (2018 - 2026)
Mereo BioPharma (MREO) posted quarterly Assets Average of $43.3 million for Q1 2026, down 40.2% year-over-year from $72.4 million in Q1 2025, and down 13.05% quarter-over-quarter from $49.8 million in Q4 2025.
Mereo BioPharma (MREO) Assets Average (2018 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Assets Average for 6 consecutive years, with $43.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average fell 40.2% year-over-year to $43.3 million; the TTM figure through Mar 2026 stood at $43.3 million (down 40.2% YoY), while the FY2025 annual figure was $61.2 million, down 14.4% from the prior year.
- Assets Average declined to $43.3 million in Q1 2026 per MREO's latest filing, from $49.8 million in the prior quarter.
- Across five years, Assets Average topped out at $92.4 million in Q3 2024 and bottomed at $43.3 million in Q1 2026.
- Historically, Assets Average has averaged $66.8 million across 3 years, with a median of $65.5 million in 2025.
- Annual changes were most pronounced in 2025 — Assets Average advanced 18.19% — and 2026, when it sank 40.2%.
- Mereo BioPharma's Assets Average stood at $82.6 million in 2024, then slumped by 39.74% to $49.8 million in 2025, then fell by 13.05% to $43.3 million in 2026.
- Business Quant data shows MREO's Assets Average at $43.3 million in Q1 2026, $49.8 million in Q4 2025, and $58.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Mereo BioPharma | 47.15 Mn | 47.15 Mn | - | 37.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.66 Mn |
| Mar 31, 2026 | 43.27 Mn |
| Dec 31, 2025 | 49.76 Mn |
| Sep 30, 2025 | 58.12 Mn |
| Jun 30, 2025 | 65.48 Mn |
| Mar 31, 2025 | 72.36 Mn |
| Dec 31, 2024 | 82.57 Mn |
| Sep 30, 2024 | 92.44 Mn |
| Jun 30, 2024 | 76.03 Mn |
| Mar 31, 2024 | 61.22 Mn |
| Jun 30, 2020 | 123.73 Mn |
| Dec 31, 2019 | 124.48 Mn |
| Jun 30, 2019 | 112.19 Mn |
| Dec 31, 2018 | 107.23 Mn |